Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Significant Growth in Short InterestMarket Beat·Jul 17 at 06:40 AMRLMD+0.39%
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | RLMD Stock NewsStockTitan·Jul 15 at 10:05 PMRLMD+0.39%
Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 Indexbenzinga_article·Jun 29 at 06:08 AMRLMD+0.39%
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Callbenzinga_article·Jun 18 at 12:38 PMRLMD+0.39%
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Jun 18 at 06:45 AMIMMX+2.00%TRNO+0.43%
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Sessionbenzinga_article·Jun 3 at 07:29 AMABVX+1.83%RLMD+0.39%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Jun 3 at 07:06 AMABVX+1.83%SNGX-2.53%
Transcript: Harrow Q1 2026 Earnings Conference Callbenzinga_article·May 12 at 10:29 AMHROW-2.57%HROWL0.00%
